Nonetheless, these findings strongly suggest that BI-TK/GCV gene therapy system may upregulate Caspase 3 expression in bladder tumors and hence promote bladder tumor cell apoptosis (Figure 4). This evidence concerns the gene CASP3 and urinary bladder neoplasm.